Danske Life Science

Danske Life Science was a Nordic venture capital and private equity fund managed by Danske Private Equity, a subsidiary of Danske Bank. Launched in the early 2000s, the fund specialized in investing in promising biotechnology and life science companies across the Nordic region, particularly in Denmark and Sweden. Its portfolio included several high-profile Danish biotech firms that later became industry leaders, such as Genmab, Zealand Pharma, and NeuroSearch. The fund played a pivotal role in the early development of the Danish biotech ecosystem by providing critical risk capital and strategic guidance to early-stage drug development companies.